A small number of enteroviral serotypes account for the majority of viral meningitis cases, suggesting a targeted vaccine could prevent most cases.
Authors
No takes yet. Share an insight, caveat, or question.
Supports targeted multivalent vaccine development against dominant serotypes; leaves open whether vaccination reduces clinical meningitis incidence.
Atkinson et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: